Key statistics
On Friday, MaxCyte Inc (MYE0:FRA) closed at 3.66, -26.21% below its 52-week high of 4.96, set on Jun 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.80 |
---|---|
High | 3.80 |
Low | 3.66 |
Bid | 3.60 |
Offer | 3.74 |
Previous close | 3.60 |
Average volume | 4.00 |
---|---|
Shares outstanding | 105.17m |
Free float | 98.51m |
P/E (TTM) | -- |
Market cap | 431.20m USD |
EPS (TTM) | -0.3408 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 14:29 BST.
More ▼
Announcements
- TR-1: Notification of major holdings
- Signing of Strategic Platform License
- MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases
- Exercise of options and PDMR dealing
- Bioprocessing Conference Participation
- MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference
- Total Voting Rights
- Exercise of options and PDMR dealing
- Filing of Form 10-Q
- Second Quarter and Half-Year Results
More ▼